Express Pharma
Home  »  Latest Updates  »  Signet-Meggle’s seminar on DPI held in Mumbai

Signet-Meggle’s seminar on DPI held in Mumbai

10

The seminar provided in-depth information on DPI technology using properties of lactose powder

Signet, distributor of excipients to the Indian pharmaceutical industry along with Meggle, a leading producer of pharma lactose recently organised a one-day seminar on Dry Powder Inhalation (DPI) in Mumbai. The seminar was held in association with Capsugel, Harro Hofliger, Team Consulting, Vamsi Labs, Aptar Pharma, Sympatec, Amcor Flexibles.

The scope of the seminar was to provide in-depth information on the DPI technology using the properties of lactose powder. Several topics were discussed like the role of Lactose in DPI; filling technologies; capsules for DPI; dispersion, de-agglomeration and aerolisation – a particle’s perspective; development of lactose-based dpi formulations: blending-filling-performance; dry powder inhalers – regulatory challenges and opportunities.

The seminar was addressed by key speakers including Dr Mirjam Dogru, Project Manager Analytics, R&D BG excipients and technology, Meggle; Marco Laackmann-Business Unit Leader Inhalation, Harro Höfliger; Dr Karlheinz Seyfang-Principal Consultant (pharmaceutical technology), Harro Höfliger; Dr Sven Stegemann- Director of Pharmaceutical Business Development, Capsugel; David Harris- Head of Respiratory Drug Delivery, Team Consulting; Dr Ravindra Purohit-Director technical, Vamsi Labs.

EP News BureauMumbai

Comments are closed.